(Mary Ann Liebert, Inc./Genetic Engineering News) A new study in children aged 6 to 12 years of dasotraline, a promising new treatment for attention deficit hyperactivity disorder (ADHD), showed significant improvement in efficacy in the treatment of ADHD compared to placebo beginning at week 1 and continuing throughout the study.
from EurekAlert! - Social and Behavioral Science http://bit.ly/2UFhsdU
No comments:
Post a Comment